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Abstract
Introduction: Heightened concerns about industry influence on
continuing medical education (CME) have prompted tighter controls on
the management of commercial funding and conflict of interest. As a
result, CME providers must closely monitor their activities and intervene
if bias or noncompliance with accreditation standards is likely. Potential
for industry influence can be difficult to assess at a stage in the planning
process when mitigation strategies can assure balance and content
validity. Few tools exist to aid providers in this regard.
Methods: A 12-item instrument was designed to assess risk for
commercial influence on CME. To determine reliability and validity, a
cohort of experienced CME professionals applied the tool to standardized
“cases” representing CME activities in the early stages of planning.
Results were compared with the experts’ assignment of the same cases
to one of four risk categories. A survey of study participants was
conducted to ascertain usefulness and potential applications of the tool.
Results: Analysis demonstrated strong intraclass correlation across
cases (0.90), interrater reliability (94%), and correlation between
assessment of risk with and without the tool (Spearman coefficient,
0.93, p < 0.01; weighted kappa, 0.59). Participants found the tool easy
to use and of potential benefit to their CME office.
Discussion: The Consortium for Academic Continuing Medical Education
(CACME) risk stratification tool can help CME providers identify activities
that must be closely monitored for potential industry influence, remain
aware of factors that place programming at risk for noncompliance with
accreditation standards, and substantiate the allocation of resources by
the CME office.
Key Words: continuing medical education, commercial interests, standards
for commercial support, risk stratification tool, risk assessment, ethical
standards, Consortium for Academic Continuing Medical Education

Introduction
Increasing levels of commercial funding for continuing medical education
(CME) in the United States have raised concerns about the effect of industry
on the quality and scientific balance of physician education as well as the
1–3

independence of the CME enterprise.
In 2006, 61% of CME revenue in the
United States was derived from commercial sources, such as the
4

pharmaceutical and medical device industry. Given that CME participants
often have difficulty determining the difference between commercial bias and
5

expert personal opinion, educators must play an active role in assuring that
programming is balanced and evidence-based. Standards promulgated by
various accrediting organizations, including the Accreditation Council for
6

Continuing Medical Education (ACCME), the American Academy of Family
7

8

Physicians, and the American Medical Association, hold CME providers
accountable for the scientific integrity of their programs. Despite the
expenditure of considerable administrative resources to adhere to regulatory
5

requirements, it is discouraging to recognize that 20% of ACCME-accredited
organizations are in noncompliance with one or more elements of the
9

Standards for Commercial Support (SCS). CME providers must develop
rigorous methods to recognize, manage, and assess commercial influence.
Tools developed for this purpose, such as surveys of participants’
perceptions of bias, are customarily used at the end of an activity when it is
too late for providers to intervene.

10

Risk stratification is a statistical process employed in medicine to determine
factors associated with adverse clinical outcomes, so that practitioners can
11,12

For example, the
develop targeted interventions to mitigate their impact.
identification of risk factors for coronary artery disease (e.g., hypertension,
diabetes, hyperlipidemia, cigarette smoking) is used as a basis for initiating
a variety of lifestyle modifications and medical interventions that can reduce
11

morbidity and mortality rates.

This approach has been employed in
13–16

numerous other clinical conditions.
Application of these principles to the
CME enterprise offers the opportunity to prospectively identify factors that
may adversely affect the balance and educational integrity of programming.
Interventions can then be developed to maintain compliance with regulatory
standards and, more importantly, provide effective learning experiences.
In 1998, the Consortium for Academic Continuing Medical Education
a

(CACME) began developing a risk stratification tool to assess potential for
commercial influence. Using nominal group and Delphi techniques, four

major factors contributing to risk were identified: (1) the nature of the
activity’s content, (2) the amount and characteristics of commercial support,
(3) the level of control of the CME office in planning and financial
management, and (4) the potential influence of commercial entities on
various stakeholders, such as course directors. Criteria for assessment of
each of these factors were refined through pilot testing, resulting in a 12item instrument )Appendix). Numerical weighting of these items permitted
calculation of an overall risk score, and ranges of scores were grouped into
categories of low, moderate, high, and very high risk, with management and
oversight processes developed for each level. Over time, results obtained
through use of the tool were compared with actual monitoring and
compliance issues of CACME activities, resulting in ongoing refinement of
item weighting and operational definitions. Participating schools have
routinely used the risk tool at the beginning of the planning process for all
activities except regularly scheduled conferences. Strategies to mitigate the
risk identified by the tool have included denial of certification, enhanced
monitoring, more rigorous resolution of conflict of interest, and increased
involvement of the CME office in educational design and logistical support.
Ongoing quality assurance reviews have demonstrated consistent
compliance of activities with the ACCME’s Standards for Commercial
Support.
Methods
The usefulness of the tool in the CACME institutions stimulated interest in its
dissemination to other CME providers. In order to enhance understanding of
the value of the instrument, a study was conducted to determine whether a
tool based on the principles of risk stratification, applied early in the
planning process, could reliably identify issues that place CME activities at
risk for commercial influence. To address this question and gain some
understanding of the validity of the tool, we asked experienced CME
providers, all of whom were knowledgeable about ACCME standards, to
assign a set of CME activity “cases” to one of four risk categories (low,
moderate, high, and very high). We compared these assessments to scores
obtained when the same individuals applied the risk tool to the cases (Figure
1).
Development of Standardized Cases
To provide a standardized evaluation environment, the “cases” were
developed to represent data commonly available early in the CME planning
process. Although these cases were based on actual CACME programs, some
characteristics were modified to create representation among the four risk

categories (low, moderate, high, and very high). Cases were placed into a
structured format that included a general description of the proposed activity
and details about the budget, funding sources, management, meals, social
events, and relationships with industry (information that would normally be
available early in the planning process). Every option for each of the 12
items included in the risk stratification tool was represented in at least two
of the cases included in the study. Preliminary evaluation of the cases for
test-retest reliability was conducted using CACME deans, administrators, and
staff who rated the cases on three separate occasions using the risk
stratification tool. As a result of this exercise, modifications were made to
improve the clarity and completeness of the information provided, yielding a
total of 36 cases (9 in each risk category).
Design
On the basis of power calculation, it was determined that at least 12 ratings
per case using the tool would be required to achieve statistically meaningful
results. Study participants, who were each assigned 24 cases representing
various levels of risk for commercial influence, were divided into two groups.
Group 1 participants were sent the cases along with the risk stratification
tool (without the associated numerical ratings), operational definitions for
each of the 12 items, and two “practice cases” to familiarize them with use
of the instrument. The individuals were asked to apply the tool to the cases
and return all materials to the study team. Three weeks later, participants
received the same cases (in different order) and were asked to assign them
to one of four risk categories. Operational definitions of each category were
provided, along with two “practice cases.” Group 2 received the cases along
with the risk categories first and then repeated the exercise 3 weeks later
using the risk stratification tool. After the second assessment, all participants
received a 17-item survey using a 5-point Likert scale to assess perceptions
of benefits, usability, and limitations of the tool.
Study Participants
A convenience sample of 22 CME professionals from across the United States
was invited to participate. Of these, 18 agreed. Participants had an average
of 13.8 years of experience in CME and worked in a variety of institutional
settings. Eleven were ACCME surveyors and 2 were ACCME staff. None of
them had ever seen or used the risk stratification tool. A $50 honorarium
was offered to each participant for completion of the study.

Statistical Analysis
Descriptive statistics were used to report the characteristics and tabulate the
responses of study participants. Assessment of the tool’s reliability was
determined by calculation of the intraclass correlation coefficient across the
36 cases. Interrater reliability was also calculated and expressed in terms of
a mean value for each item and for all items.
To assess the tool’s validity, total risk stratification scores were correlated
with the assigned risk categories across the 36 cases. Results were
expressed in terms of the Spearman correlation coefficient, which is a
correlation between the level of risk as determined by the tool and the
assigned risk categories across all cases. Weighted kappa, which is ordinarily
considered to be a measure of consistency assessing agreement among
raters extending beyond chance, was employed to assess validity. Validity
was determined by consistency between the total risk score and the
participants’ assignments to a risk category without benefit of the tool.
To assess the tool’s usefulness, Likert scores were tabulated for each survey
item and the mean score was calculated for each. Analyses were performed
with Stata (StataCorp, College Station, TX) and SAS (SAS Institute, Cary,
NC) in the Data Center at the University of Pittsburgh Center for Research
on Health Care.
Results
All participants completed the study. One set of data was incomplete and
therefore unusable. The reliability of the tool among the different raters was
strong. The intraclass correlation coefficient was 0.90, based on 36 cases
(Table 1). Interrater reliability was calculated by the average agreement for
each item. Results indicated strong interrater reliability of the tool, with an
average agreement of 94% for all items (standard deviation = 9.27). The
two items with the lowest degrees of reliability were the delegation of
logistical responsibilities to another party (89%) and the level of
involvement of a commercial supporter in suggesting topics (90%). Each of
the remaining items showed greater than 90% agreement.
In order to assess association and bias, we calculated the percentage
agreement across raters for each of the cases. Across all 36 cases, the
percentage agreement ranged from 85% to 99%, with an average
agreement of 94%. This result demonstrates that the differences in scores
were not attributable to the differences among the raters.
The validity of the tool was assessed using two methods. First, we calculated

the correlation across the 36 cases between the tool and the subjective
rating of the cases. Because of the small sample size, the four risk
categories were collapsed to two, combining the low and moderate levels
(low risk) and the high and very high levels (high risk). Using this
methodology, the Spearman correlation coefficient was 0.93 ( p < 0.01),
indicating a good correlation between the categories determined through use
of the risk score and those assigned by the raters. Second, we estimated a
weighted kappa to determine the extent to which the overall score obtained
through use of the tool is consistent with the participants’ categorical
assignments. To estimate the kappa, 24 ratings for each case were used (12
ratings using the tool and 12 from category assignment), yielding a sample
b

size of 408. The correlation between the total risk score determined by the
tool and level of risk assigned by the raters was strong. The results of the
weighted kappa also showed positive results with a kappa of 0.59. A kappa
17

between .40 and .60 is considered reasonable agreement. Thus the kappa
score indicates that the assessment of risk obtained through utilization of
the tool is on par with that obtained utilizing expert judgment of the study
participants (expert CME professionals).
Of the 18 participants, 17 (94%) submitted complete rating data and 15
(83%) returned surveys. Survey responses (TABLE 2) indicated that the tool
has clear operating definitions (mean score of 4.0 on a 5-point Likert scale),
can be helpful in allocating resources to high-risk activities (4.20), has
potential use for teaching staff about standards for commercial support
(4.47), and can assist CME professionals in thinking about issues that affect
compliance with the Standards for Commercial Support (4.67). Fourteen of
15 respondents agreed or were neutral about the potential use of the tool by
the ACCME to select files for accreditation surveys, but 5 indicated that they
would not want to share such information with the ACCME.
Discussion
Under increased pressure to prevent industry influence, CME providers must
develop mechanisms for consistently identifying and managing vulnerable
activities. Risk stratification methods have been employed in multiple areas
of health care and in other disciplines. However, a review of the literature
reveals only one article in which these methods were used to assess
18

educational outcomes. This study demonstrates a way to apply risk
stratification principles to assess the potential for a CME activity to be
influenced by industry, and therefore noncompliance with ACCME Standards
for Commercial Support. Our results indicate that the CACME risk

stratification tool provides a mechanism to estimate risk that is reliable,
potentially valid (as judged by the standard of expert assessment of risk),
and useful to CME providers.
Two principles of risk assessment are particularly relevant to CME. One is
the prediction of risk, with an emphasis on identification of risk factors and
stratification of overall risk. The other is the management of risk, with an
17

emphasis on risk reduction. The CACME tool addresses both principles.
First, by helping CME professionals identify factors that can contribute to
noncompliance with standards, the tool prompts data collection about
specific program issues that are critical to maintenance of compliance.
Second, once risk factors have been identified, planners can develop
strategies to mitigate these factors. The higher the category of risk, the
greater the need for “risk management,” including such actions as stringent
monitoring, review of documentation, and allocation of resources and
personnel to ensure compliance. Thus, the CACME risk stratification tool
provides a prediction that can influence the decision about whether to certify
a given CME activity and can guide management throughout planning and
development. In addition, the tool may be useful for training CME staff and
educating activity directors, joint sponsors, funders, and other individuals
who contribute to the implementation process. Finally, compilation of
aggregate risk scores and data about individual activities allows providers to
evaluate their overall CME program.
CACME’s work demonstrates the value of multiinstitutional collaboration in
addressing complex issues associated with educational planning and
certification. In developing the tool, the iterative process we employed drew
on the expertise of leaders from all member schools. It is unlikely that any
single individual or institution could have developed such a tool in isolation.
Applying the tool across the consortium allowed us to monitor the
performance of the individual members and the consortium as a whole. This,
in turn, expanded CACME’s ability to use the tool for decision making,
program planning, and evaluation.
Limitations
This study used CME experts to determine a “gold standard” of potential risk
(assignment of cases to a risk category) against which the tool was
measured. The ideal design to test our instrument would be a naturalistic
study in which activities were assessed with the tool and then allowed to
proceed without any intervention by the accredited provider (analogous to
the natural course of disease), with a follow-up evaluation to determine
whether commercial influence or noncompliance with accreditation standards
was present. However, this situation does not occur in the real world

because accredited providers do intervene to assure compliance.
Determination of risk factors in the clinical setting is customarily
accomplished through the use of large epidemiologic studies. Such an
approach is beyond the scope of this study. We relied on participants’
experience as providers and their knowledge of accreditation requirements
to make accurate determinations of potential risk and recognize that this
approach limits conclusions about the validity of the tool. However, the
validity of the instrument demonstrated in this study has been supported by
experience within CACME that indicates frequent compliance issues in
activities with high risk scores.
Another concern is that simulated cases were used rather than real activity
files. Although the cases were based on actual CME programs, several were
modified to represent high-risk activities and to ensure a balanced number
of activities in all four risk categories. While this method may not reflect the
actual case mix of an accredited CME provider, we wanted to emphasize
detection of “outlier” high-risk activities; although they are uncommon, it is
critically important to identify them in order to maintain compliance. We also
recognize that the information was provided in a structured and consistent
fashion, addressing the elements of the activity appropriate to the items
contained within the tool. In the day-to-day practice of CME, some data may
not be readily available early in the planning process and the individuals
using the tool may not be knowledgeable about some of the factors (such as
previous experience with a joint sponsor or logistical partner). As a result,
the reliability of the tool may be lower than observed in this study.
The size and characteristics of our study sample are relatively limited by the
number of available CME experts. Because of the size, the four risk
categories were collapsed into two for purposes of one of the measures of
validity, limiting conclusions about the discriminatory capacity of the tool
across the wide range of risk. The use of seasoned CME professionals in this
study also raises questions about the ability to generalize use of the tool
among CME providers with varying backgrounds and experience. Longstanding implementation within the four CACME institutions indicates that
staff at all levels can use the instrument with reliable results. In addition,
study participants indicated that the tool would be useful in their offices.
It is possible that some important risk factors are not included in our tool.
During development, some factors that were difficult to quantify or
operationally define were excluded. Additional use and evaluation of the tool
may permit incorporation of such factors.
Conclusions

The CACME Risk Stratification Tool supports the prospective identification of
CME activities that may be at risk for commercial influence. The 12-item tool
is easy to use and allows users to categorize each CME activity’s potential for
noncompliance as low, medium, high, or very high. The results of a casebased crossover study confirm that the tool is reliable and may have
predictive value in terms of risk for commercial influence. A survey of users
indicates that it would be useful for objectively assessing a CME program in
the planning stage. In addition, the tool can assist in teaching staff about
standards for commercial support of CME activities, help individuals identify
issues that affect compliance with the standards, and support administrators
in allocating resources to mitigate the risks of noncompliance. Through the
use of this tool, CME providers can define rational and consistent strategies
for certification and management of activities. Such an approach may be
particularly beneficial in large, decentralized programs that delegate many of
these responsibilities to individuals outside the CME office.
There is increasing public demand for transparency and management of
19,20

relationships between health care organizations and industry.
It is
critically important for CME providers to assure that educational
programming is evidence-based, balanced, free of commercial influence, and
effective. Instruments such as the risk stratification tool provide an objective
and systematic means to assess the level of involvement by external entities
prospectively in order to allocate appropriate resources to foster compliance
with regulatory standards and preserve educational integrity.
Lessons for Practice
•

It is incumbent upon CME providers to implement mechanisms to
assure that activities are free of commercial influence and bias.

•

Risk stratification provides a mechanism to identify commercial
influence in CME and mitigate risk for noncompliance with ACCME
Standards for Commercial Support.

•

A risk stratification tool has proved reliable, valid, and useful in
identifying CME activities at risk for commercial influence.
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Notes
a.

CACME members consisted of Jefferson Medical College, Penn State
College of Medicine, Temple University, and the University of
Pittsburgh. In 2005, CACME was disbanded as an accredited
consortium, but the four schools continue to collaborate on this and
other projects.

b.

Traditionally kappa is considered a measure of consistency. However,
when one of those measures is the standard by which the other is
judged (in this case, the expert judgment of risk), one can infer the
validity of the second measure to the extent that it is consistent with
that standard.
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Appendix: CACME Risk Stratification Tool
NAME OF ACTIVITY: _________________________________________
1.

Joint sponsorship
Activity is directly sponsored, no joint sponsors: 0
Activity is jointly sponsored and all joint sponsors are nonprofit
organizations: 1
Activity is jointly sponsored and some or all joint sponsors are for-profit
organizations: 2

2.

Experience with jointly sponsoring organizations
Activity is directly sponsored, no joint sponsors: 0
Positive experience with all jointly sponsoring organization(s): -1
No prior experience with one or more of the jointly sponsoring
organizations: 1
Some negative experiences with one or more of the jointly sponsoring
organizations: 3

3.

Commercially supported activity with a standard curriculum
delivered at multiple locations
No commercial support: 0
Commercial support but the activity does not feature multiple
presentations of the same curriculum at different locations: 0
Commercially supported activity with multiple presentations of the
same curriculum at different locations: 3

4.

Responsibility for course logistics
Handled entirely by staff from the CME office: 0
Some or all responsibilities delegated by the CME office to one or
more entities: 1
Some or all responsibilities delegated by a joint sponsor to one or
more entities: 2
Some or all of logistics performed by an organization suggested or
chosen by a commercial supporter:3

5.

Experience with the entity(ies) external to the CME office
responsible for some or all of logistics
Not applicable (all logistics handled by the CME office):0
Positive experience working with the entity(ies): -1
No experience working with the entity(ies):1
Negative experience with the entity(ies):3

6.

Responsibility for funds management
The CME activity has no income or expenses: 0
Funds management handled entirely by staff from the CME office: 0
Some or all funds management handled by a not-for-profit entity
outside the CME office: 2
Some or all funds management handled by a for-profit entity external
to the CME office: 3

7.

Number of commercial supporters
No commercial support for the course: 0
Two or more commercial supporters: 2
One commercial supporter with whom the accredited provider has
worked and has had good experiences: 3
One commercial supporter with whom the accredited provider has
never worked: 4
One commercial supporter with whom the accredited provider has
worked and has had negative experiences: 5

8.

Anticipated amount of commercial support as a percentage of
the anticipated total revenue
No commercial support: 0
Up to 50% of course revenue will be from commercial support: 1
51% to 99% of course revenue will be from commercial support: 3
100% of course revenue will be from commercial support: 4

9.

Level of involvement of any commercial supporter(s) (choose
all that apply): MAXIMUM SCORE OF 3

No commercial support: 0
Commercial support but no involvement of any commercial supporters
with the logistical or educational aspects of the activity: 1
Assistance from the commercial supporter with marketing: 1
Suggestion from the commercial supporter for course location: 1
Recommendation from the commercial supporter of potential
participants: 1
Recommendation from the commercial supporter of the topic area: 1
Recommendation from the commercial supporter of one or more
speakers: 1
10. Anticipated amount of exhibit funds as a percentage of
anticipated total revenue of the activity
There will be no exhibit revenue: 0
Up to 50% of course revenue will be from exhibit revenue: 1
51% to 100% of course revenue will be from exhibit revenue: 2
11. Discussion of experimental and/or off-label uses
Primary intent does not involve the discussion of experimental and0or
off-label uses: 0
Primary intent does involve the discussion of experimental and0or offlabel uses: 2
12. Relationships between the course director(s) and industry that
might affect the scientific balance of the content
No relationships exist between course director(s) and industry that are
likely to affect the scientific balance: 0
Relationships exist between course director(s) and industry that are
likely to affect the scientific balance of the activity: 2
TOTAL SCORE ________
RISK CATEGORY:
____
____
____
____

LOW (≤ 2)
MODERATE (3 TO 11)
HIGH (12 TO 19)
VERY HIGH: (≥ 20)

Figures and Tables
Figure 1. Study design.

Table 1. Summary of Statistical Analysis
Reliability

Validity

Average
agreement
94%
(standard
deviation =
9.27)

Intraclass
correlation
coefficient,
single rater

Spearman
correlation
coefficient

Weighted
kappa

.9030
p = 0.000
(n = 36)

0.932
p < 0.01
(n = 36)

0.5866
p = 0.0263
(n = 408)

Table 2. Participant Survey Results
1
2
3
4
5
6
7
8
9
10
11

12
13

The risk stratification tool makes me think about issues that affect
compliance with the Standards for Commercial Support
The risk tool is difficult to use.
The operational definitions for the elements of the risk
stratification tool are clear and easy to understand.
Use of the risk stratification tool is time consuming.
Routine use of the risk stratification tool would help my CME
department decide which activities to certify.
Routine use of the risk stratification tool would assist my CME
office in allocating resources to activities at higher risk of
noncompliance with ACCME requirements.
The risk stratification tool would be useful for teaching staff about
issues associated with the Standards for Commercial Support.
It would take a long time to train my staff to use the risk
stratification tool.
Results obtained through the use of the risk stratification tool
would be useful to the ACCME in deciding which files to review
during accreditation surveys.
I would not want to share the risk information obtained through
use of the risk stratification tool with the ACCME.
Information obtained through use of the risk stratification tool
would be helpful in justifying to course directors and joint
sponsors why certain requirements of the CME office are
necessary.
Use of the risk stratification tool would help to justify why the CME
department assesses higher fees for certain activities.
The concept of a risk stratification tool is potentially very valuable

4.67
1.80
4.00
2.67
3.73
4.20
4.47
2.13
3.60
2.93
4.47

4.00
2.00

but the instrument provided is not adequate.
14 Certain key elements are missing from the risk stratification tool
2.54
that was provided.
15 Use of the risk stratification tool adds little to my own subjective assessment 2.33
of an activity’s potential risk for noncompliance with the ACCME Standards
for Commercial Support.
16 I would like to use the risk stratification tool routinely in my CME
4.00
office.
17 Information obtained through use of the risk stratification tool
4.27
would be helpful in explaining to industry representatives why
certain requirements of the CME office are necessary.
Note: 1 = Strongly disagree; 2 = Disagree; 3 = Neutral; 4 = Agree; 5 =
Strongly agree.

